drug · gene
patient view →pexastimogene devacirepvec
Phase 2updated 2mo agoby Sillajen Biotherapeutics🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Granulocyte-macrophage colony-stimulating factor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that